126 related articles for article (PubMed ID: 9181753)
21. Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study.
Butthep P; Bunyaratvej A; Funahara Y; Kitaguchi H; Fucharoen S; Sato S; Bhamarapravati N
Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():141-148A. PubMed ID: 9640617
[TBL] [Abstract][Full Text] [Related]
22. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.
Thorand B; Baumert J; Chambless L; Meisinger C; Kolb H; Döring A; Löwel H; Koenig W;
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):398-405. PubMed ID: 16322530
[TBL] [Abstract][Full Text] [Related]
23. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
[TBL] [Abstract][Full Text] [Related]
24. Assessment of platelets and the endothelium in patients presenting with acute coronary syndromes--is there a future?
Derhaschnig U; Jilma B
Thromb Haemost; 2009 Dec; 102(6):1144-8. PubMed ID: 19967144
[No Abstract] [Full Text] [Related]
25. Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.
Luzzatto G; Cella G; Messina C; Randi ML; Sbarai A; Zanesco L
Med Pediatr Oncol; 2003 Jan; 40(1):9-12. PubMed ID: 12426679
[TBL] [Abstract][Full Text] [Related]
26. Acute effects of periodontal therapy on bio-markers of vascular health.
D'Aiuto F; Parkar M; Tonetti MS
J Clin Periodontol; 2007 Feb; 34(2):124-9. PubMed ID: 17214734
[TBL] [Abstract][Full Text] [Related]
27. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease.
Blann AD; Seigneur M; Steiner M; Boisseau MR; McCollum CN
Eur J Clin Invest; 1997 Nov; 27(11):916-21. PubMed ID: 9395787
[TBL] [Abstract][Full Text] [Related]
28. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
Apras S; Ertenli I; Ozbalkan Z; Kiraz S; Ozturk MA; Haznedaroglu IC; Cobankara V; Pay S; Calguneri M
Arthritis Rheum; 2003 Aug; 48(8):2256-61. PubMed ID: 12905480
[TBL] [Abstract][Full Text] [Related]
29. Neutrophil elastase, von Willebrand factor, soluble thrombomodulin and percutaneous oxygen in peripheral atherosclerosis.
Blann AD; Seigneur M; Adams RA; McCollum CN
Eur J Vasc Endovasc Surg; 1996 Aug; 12(2):218-22. PubMed ID: 8760986
[TBL] [Abstract][Full Text] [Related]
30. Can von Willebrand factor, platelet-endothelial cell adhesion molecule-1 and thrombomodulin be used as alternative markers of endothelial cell injury in human glomerulonephritis?
Niemir ZI; Kubiak A; Olejniczak P; Nowak A; Czekalski S
Rocz Akad Med Bialymst; 2004; 49():213-8. PubMed ID: 15631346
[TBL] [Abstract][Full Text] [Related]
31. [Measurement of biological parameters of endothelial origin: value in human pathology].
Sampol J; George F
Ann Biol Clin (Paris); 1995; 53(6):329-38. PubMed ID: 8572378
[TBL] [Abstract][Full Text] [Related]
32. Endothelial markers and adhesion molecules in acute ischemic stroke--sequential change and differences in stroke subtype.
Kozuka K; Kohriyama T; Nomura E; Ikeda J; Kajikawa H; Nakamura S
Atherosclerosis; 2002 Mar; 161(1):161-8. PubMed ID: 11882328
[TBL] [Abstract][Full Text] [Related]
33. [Molecular markers of endothelial dysfunction in acute ischemic stroke].
Szegedi N; May Z; Ováry C; Skopál J; Nagy Z
Ideggyogy Sz; 2002 Mar; 55(3-4):102-8. PubMed ID: 12122979
[TBL] [Abstract][Full Text] [Related]
34. The influence of smoking on soluble adhesion molecules and endothelial cell markers.
Blann AD; Steele C; McCollum CN
Thromb Res; 1997 Mar; 85(5):433-8. PubMed ID: 9076900
[No Abstract] [Full Text] [Related]
35. Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers.
Seljeflot I; Arnesen H; Brude IR; Nenseter MS; Drevon CA; Hjermann I
Eur J Clin Invest; 1998 Aug; 28(8):629-35. PubMed ID: 9767357
[TBL] [Abstract][Full Text] [Related]
36. Endothelial marker proteins in hyperhomocysteinemia.
de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
[TBL] [Abstract][Full Text] [Related]
37. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
38. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
39. Significance of soluble P-selectin, von Willebrand factor, and other adhesion molecules in hypercholesterolemia and peripheral artery disease.
Blann AD; Lip GY; Fijnheer R
Circulation; 1999 May; 99(18):2478-9. PubMed ID: 10318743
[No Abstract] [Full Text] [Related]
40. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.
Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
Thromb Res; 2009 Sep; 124(4):452-7. PubMed ID: 19477487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
